[1] |
Al Kury LT. Calcium homeostasis in ventricular myocytes of diabetic cardiomyopathy[J]. J Diabetes Res, 2020, 2020: 1942086. doi: 10.1155/2020/1942086
|
[2] |
Jia X, Xiao C, Sheng D, et al. TRPV4 mediates cardiac fibrosis via the TGF-β1/Smad3 signaling pathway in diabetic rats[J]. Cardiovasc Toxicol, 2020, 20(5): 492 – 499. doi: 10.1007/s12012-020-09572-8
|
[3] |
Wu QR, Zheng DL, Liu PM, et al. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy[J]. Cell Death Dis, 2021, 12(2): 216. doi: 10.1038/s41419-021-03502-4
|
[4] |
Jiang SJ. Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury[J]. World J Diabetes, 2022, 13(4): 338 – 357. doi: 10.4239/wjd.v13.i4.338
|
[5] |
Fouda MA, Ghovanloo MR, Ruben PC. Cannabidiol protects against high glucose-induced oxidative stress and cytotoxicity in cardiac voltage-gated sodium channels[J]. Br J Pharmacol, 2020, 177(13): 2932 – 2946. doi: 10.1111/bph.15020
|
[6] |
Shi YQ, Yan M, Liu LR, et al. High glucose represses hERG K+ channel expression through trafficking inhibition[J]. Cell Physiol Biochem, 2015, 37(1): 284 – 296. doi: 10.1159/000430353
|
[7] |
Meo M, Meste O, Signore S, et al. Reduction in Kv current enhances the temporal dispersion of the action potential in diabetic myocytes: insights from a novel repolarization algorithm[J]. J Am Heart Assoc, 2016, 5(2): e003078. doi: 10.1161/JAHA.115.003078
|
[8] |
Hegyi B, Borst JM, Bailey LRJ, et al. Hyperglycemia regulates cardiac K(+) channels via O-GlcNAc-CaMKII and NOX2-ROS-PKC pathways[J]. Basic Res Cardiol, 2020, 115(6): 71. doi: 10.1007/s00395-020-00834-8
|
[9] |
Wang J, Bai J, Duan P, et al. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway[J]. J Cell Mol Med, 2021, 25(8): 3935 – 3949. doi: 10.1111/jcmm.16346
|
[10] |
Asano S, Tune JD, Dick GM, et al. Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscle[J]. Br J Pharmacol, 2010, 160(1): 160 – 170. doi: 10.1111/j.1476-5381.2010.00687.x
|
[11] |
张 恒, 陶 敏, 康品方, 等. 活化的乙醛脱氢酶2通过调节双孔钾离子通道TASK-1减轻糖尿病大鼠心肌损伤[J]. 中南大学学报(医学版), 2019, 44(1): 14 – 21. doi: 10.11817/j.issn.1672-7347.2019.01.003
|
[12] |
Hadova K, Kralova E, Doka G, et al. Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy[J]. BMC Cardiovasc Disord, 2021, 21(1): 118. doi: 10.1186/s12872-021-01929-3
|
[13] |
Yamamoto S, Ichishima K, Ehara T. Reduced volume-regulated outwardly rectifying anion channel activity in ventricular myocyte of type 1 diabetic mice[J]. J Physiol Sci, 2009, 59(2): 87 – 96. doi: 10.1007/s12576-008-0012-8
|
[14] |
Wang L, Shen M, Guo X, et al. Volume-sensitive outwardly rectifying chloride channel blockers protect against high glucose-induced apoptosis of cardiomyocytes via autophagy activation[J]. Sci Rep, 2017, 7: 44265. doi: 10.1038/srep44265
|
[15] |
Sasaki K, Donthamsetty R, Heldak M, et al. VDAC: old protein with new roles in diabetes[J]. Am J Physiol Cell Physiol, 2012, 303(10): C1055 – C1060. doi: 10.1152/ajpcell.00087.2012
|
[16] |
蔡少艾, 陈景福, 陈美姬, 等. 血管紧张素(1-7)通过抑制ClC-3通道减轻高糖引起的心肌细胞损伤[J]. 南方医科大学学报, 2017, 37(7): 895 – 901. doi: 10.3969/j.issn.1673-4254.2017.07.07
|
[17] |
Gaines H, Jones KR, Lim J, et al. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes[J]. J Diabetes Complications, 2021, 35(6): 107845. doi: 10.1016/j.jdiacomp.2020.107845
|
[18] |
Zhao LG, Li PL, Dai Y, et al. Mibefradil alleviates high-glucose–induced cardiac hypertrophy by inhibiting PI3K/Akt/mTOR-mediated autophagy[J]. J Cardiovasc Pharmacol, 2020, 76(2): 246 – 254. doi: 10.1097/FJC.0000000000000844
|
[19] |
Xu X, Ruan L, Tian X, et al. Calcium inhibitor inhibits high glucoseinduced hypertrophy of H9C2 cells[J]. Mol Med Rep, 2020, 22(3): 1783 – 1792. doi: 10.3892/mmr.2020.11275
|
[20] |
Bao SL, Pan J, Sun HX, et al. Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII[J]. Eur Rev Med Pharmacol Sci, 2018, 22(16): 5327 – 5334. doi: 10.26355/eurrev_201808_15733
|
[21] |
王 攀, 彭菊琴, 陈潇潇, 等. 尼可地尔通过 NLRP3 /Caspase-1 通路对糖尿病心肌病大鼠心脏损伤的影响[J]. 疑难病杂志, 2022, 21(5): 522 – 526,531. doi: 10.3969/j.issn.1671-6450.2022.05.016
|
[22] |
孙健斌, 袁 宁, 柴三葆, 等. 口服降糖药物对心血管系统的影响[J]. 中国老年学杂志, 2016, 36(10): 2548 – 2550. doi: 10.3969/j.issn.1005-9202.2016.10.112
|
[23] |
李永光, 徐伟泽, 魏钧伯, 等. 恩格列净保护心肌及调控线粒体功能的机制研究[J]. 医学综述, 2022, 28(8): 1463 – 1467. doi: 10.3969/j.issn.1006-2084.2022.08.002
|